511 related articles for article (PubMed ID: 36632509)
1. Nanomaterial-assisted theranosis of bone diseases.
Zheng K; Bai J; Yang H; Xu Y; Pan G; Wang H; Geng D
Bioact Mater; 2023 Jun; 24():263-312. PubMed ID: 36632509
[TBL] [Abstract][Full Text] [Related]
2. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy.
Murugan C; Sharma V; Murugan RK; Malaimegu G; Sundaramurthy A
J Control Release; 2019 Apr; 299():1-20. PubMed ID: 30771414
[TBL] [Abstract][Full Text] [Related]
3. Gold Nanomaterials and Bone/Cartilage Tissue Engineering: Biomedical Applications and Molecular Mechanisms.
Shi Y; Han X; Pan S; Wu Y; Jiang Y; Lin J; Chen Y; Jin H
Front Chem; 2021; 9():724188. PubMed ID: 34307305
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
[TBL] [Abstract][Full Text] [Related]
5. Nanomaterials for treating cardiovascular diseases: A review.
Jiang W; Rutherford D; Vuong T; Liu H
Bioact Mater; 2017 Dec; 2(4):185-198. PubMed ID: 29744429
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional Cellular Materials Based on 2D Nanomaterials: Prospects and Challenges.
Qiu L; He Z; Li D
Adv Mater; 2018 Jan; 30(4):. PubMed ID: 29149537
[TBL] [Abstract][Full Text] [Related]
7. An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy.
Wang Y; Santos A; Evdokiou A; Losic D
J Mater Chem B; 2015 Sep; 3(36):7153-7172. PubMed ID: 32262822
[TBL] [Abstract][Full Text] [Related]
8. Protein adsorption onto nanomaterials engineered for theranostic applications.
Nienhaus K; Xue Y; Shang L; Nienhaus GU
Nanotechnology; 2022 Apr; 33(26):. PubMed ID: 35294940
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicines for Renal Management: From Imaging to Treatment.
Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in nanomaterial-mediated bacterial molecular action and their applications in wound therapy.
Wu W; Duan M; Shao S; Meng F; Qin Y; Zhang M
Biomater Sci; 2023 Oct; 11(20):6748-6769. PubMed ID: 37665317
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for the experimental design of pharmacokinetic studies with nanomaterials in preclinical animal models.
Valic MS; Halim M; Schimmer P; Zheng G
J Control Release; 2020 Jul; 323():83-101. PubMed ID: 32278829
[TBL] [Abstract][Full Text] [Related]
12. Tissue-Engineered Nanomaterials Play Diverse Roles in Bone Injury Repair.
Wan T; Zhang M; Jiang HR; Zhang YC; Zhang XM; Wang YL; Zhang PX
Nanomaterials (Basel); 2023 Apr; 13(9):. PubMed ID: 37176994
[TBL] [Abstract][Full Text] [Related]
13. Nanomaterials in the treatment and diagnosis of rheumatoid arthritis: Advanced approaches.
Angela S; Fadhilah G; Hsiao WW; Lin HY; Ko J; Lu SC; Lee CC; Chang YS; Lin CY; Chang HC; Chiang WH
SLAS Technol; 2024 Jun; 29(4):100146. PubMed ID: 38844139
[TBL] [Abstract][Full Text] [Related]
14. Functional DNA-containing nanomaterials: cellular applications in biosensing, imaging, and targeted therapy.
Liang H; Zhang XB; Lv Y; Gong L; Wang R; Zhu X; Yang R; Tan W
Acc Chem Res; 2014 Jun; 47(6):1891-901. PubMed ID: 24780000
[TBL] [Abstract][Full Text] [Related]
15. Metal-based nano-delivery platform for treating bone disease and regeneration.
Liu Y; Xu Z; Qiao M; Cai H; Zhu Z
Front Chem; 2022; 10():955993. PubMed ID: 36017162
[TBL] [Abstract][Full Text] [Related]
16. Aptamer Nanomaterials for Ovarian Cancer Target Theranostics.
Zhao J; Tan W; Zheng J; Su Y; Cui M
Front Bioeng Biotechnol; 2022; 10():884405. PubMed ID: 35419352
[TBL] [Abstract][Full Text] [Related]
17. Inorganic nanomaterials with rapid clearance for biomedical applications.
Wang X; Zhong X; Li J; Liu Z; Cheng L
Chem Soc Rev; 2021 Aug; 50(15):8669-8742. PubMed ID: 34156040
[TBL] [Abstract][Full Text] [Related]
18. Carbon nanomaterials as versatile platforms for theranostic applications.
Kim M; Jang J; Cha C
Drug Discov Today; 2017 Sep; 22(9):1430-1437. PubMed ID: 28533188
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
[TBL] [Abstract][Full Text] [Related]
20. Translating Biomarkers of Cholangiocarcinoma for Theranosis: A Systematic Review.
Wijetunga I; McVeigh LE; Charalambous A; Antanaviciute A; Carr IM; Nair A; Prasad KR; Ingram N; Coletta PL
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 33007872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
